Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bristol-Myers Squibb (NY: BMY )

60.28 +0.47 (+0.79%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
70 71 Next >
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Exposures Fossil Fuels
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
Via Benzinga
Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast
Bristol Myers Squibb reported Q2 revenues of $12.2 billion, surpassing the consensus of $11.55B, driven by its Growth Portfolio and Eliquis. The company's adjusted EPS of $2.07 beat expectations of... 
Via Benzinga
Topics Earnings
Exposures Financial
Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps
The drug giant also raised guidance. 
Via Investor's Business Daily
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
Via Benzinga
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
From Bristol Myers Squibb
Via Business Wire
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
What the Options Market Tells Us About Bristol-Myers Squibb
Via Benzinga
High Dividend 50: Bristol-Myers Squibb
This article will examine the prospects of Bristol-Myers as an investment opportunity. 
Via Talk Markets
Bristol-Myers Squibb Unusual Options Activity For July 15
Via Benzinga
Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday
Via Benzinga
DECK, SKX Higher After Earnings; PCE On Tap Friday
It’s tough to get a firm handle on this market. One day it looks like a trading rotation into undervalued equities from big run-ups elsewhere, the next day it’s a major selloff across the board. 
Via Talk Markets
2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You?
Billionaires are buying these stocks, but that doesn't necessarily make them right for your portfolio. 
Via The Motley Fool
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK... 
Via Benzinga
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market. 
Via Benzinga
3 Defensive Stocks to Shield Your Portfolio in July
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
7 Value Stocks to Buy at a 52-Week Low in July
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows. 
Via InvestorPlace
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
From Bristol Myers Squibb
Via Business Wire
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
These stocks all pay more than four times the S&P 500 average. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever
These businesses are begging to be bought. 
Via The Motley Fool
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal
In other news, Sichuan Biokin Pharma has filed for an IPO on the Hong Kong Exchange; more on the Biosecure Act being pushed by US Speaker of the House Johnson. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
These stocks all yield more than 3%. 
Via The Motley Fool
2 Pharma Stocks to Buy Hand Over Fist This Month
These drugmakers may not be in perfect health right now, but that shouldn't last much longer. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
70 71 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.